- 公司资讯
- 市场资讯 | 2024年05月14日 20:013家企业获得后轮融资｜股权投资周报
- finviz | 2022年04月26日 20:15Protagenic Therapeutics to Present at the B. Riley Securities Neuro and Ophthalmology Virtual Investor Conference on April 27th
- finviz | 2021年11月16日 21:58Protagenic Therapeutics Announces Third Quarter 2021 Results and Business Update
- finviz | 2021年08月30日 21:15Protagenic Therapeutics to Host Virtual Science Review Wednesday, September 8th at 10 AM ET
- finviz | 2021年08月17日 19:45Protagenic Therapeutics Announces Second Quarter 2021 Results and Provides Business Update
- finviz | 2021年07月24日 04:21Protagenic Therapeutics Updates Timeline for Commencement of Patient Enrollment for PT00114 Clinical Trial
- finviz | 2021年07月08日 23:2050+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021
- finviz | 2021年07月06日 18:17Protagenic Therapeutics to Host Webinar with Dr. Maurizio Fava for its Lead Molecule PT00114 on Tuesday, July 13th at 10:00 AM ET
- finviz | 2021年06月23日 21:3550+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021
- finviz | 2021年06月16日 21:15Protagenic Therapeutics to Present at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on June 17th
- finviz | 2021年04月30日 03:06Protagenic Therapeutics, Inc. Announces Closing of $13.2 Million Public Offering and Uplisting to Nasdaq
- finviz | 2021年04月27日 08:58Protagenic Therapeutics, Inc. Announces Nasdaq Uplisting and
- finviz | 2020年12月16日 21:15Dr. Maurizio Fava of Massachusetts General Hospital to Serve as Principal Investigator for PT00114 Clinical Trial
- finviz | 2020年09月09日 00:10Protagenic Therapeutics Completes $2.0 Million Convertible Note Financing
首页
上页
下页